Prostatic ductal adenocarcinoma is a subtype of

Similar documents
Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance

ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein.

INTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein

Although current American Cancer Society guidelines

3/28/2017. Disclosure of Relevant Financial Relationships. GU Evening Subspecialty Case Conference. Differential Diagnosis:

PSA. HMCK, p63, Racemase. HMCK, p63, Racemase

Clinicopathological Features of Prostate Ductal Carcinoma: Matching Analysis and Comparison with Prostate Acinar Carcinoma

Pathology of the Prostate. PathoBasic Tatjana Vlajnic

ACCME/Disclosures. Cribriform Lesions of the Prostate. Case

Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017

Ductal adenocarcinoma of the prostate: A clinicopathological study

Although partial atrophy is one of the most common

Diagnosis, pathology and prognosis including variant pathology

Metachronous anterior urethral metastasis of prostatic ductal adenocarcinoma

5/21/2018. Difficulty in Underdiagnosing Prostate Cancer. Diagnosis of Prostate Cancer. Evaluation of Prostate Cancer and Atypical on Needle Biopsy

They Do Look Alike : Mimics of Prostate Cancer in Biopsy Samples

Prostate Pathology: Prostate Carcinoma, variants and Gleason Grading (Part 1)

Gleason Scoring System 2017 JASREMAN DHILLON, MD ASSOCIATE PROFESSOR, DEPARTMENT OF ANATOMIC PATHOLOGY, MOFFITT CANCER CENTER, TAMPA, FLORIDA

Department of Diagnostic Pathology, Kochi Red Cross Hospital, Kochi, Japan

2016 WHO CLASSIFICATION OF TUMOURS OF THE PROSTATE. Peter A. Humphrey, MD, PhD Yale University School of Medicine New Haven, CT

Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of

Intraductal Carcinoma of the Prostate

3/23/2017. Significant Changes in Prostate Cancer Classification, Grading, Staging and Reporting. Disclosure of Relevant Financial Relationships

Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma

Introduction. Key Words: high-grade prostatic intraepithelial neoplasia, HGPIN, radical prostatectomy, prostate biopsy, insignificant prostate cancer

Inverted (hobnail) high grade prostatic intraepithelial neoplasia and invasive inverted pattern

Epithelial Columnar Breast Lesions: Histopathology and Molecular Markers

ROLE OF PROSTATIC BASAL CELL MARKER IN DIAGNOSIS OF PROSTATIC LESIONS

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles

PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA AND IMPORTANT MIMICKERS PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA

Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity

Synonyms. Nephrogenic metaplasia Mesonephric adenoma

Proliferative Epithelial lesions of the Breast. Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London

Prostate Immunohistochemistry. Literature Interpretation: Caveats. Must be aware of staining pattern of antibody in the relevant tissue

Supplemental Information

Prostatic ductal adenocarcinoma: An aggressive variant that is underdiagnosed and undersampled on transrectal ultrasound (TRUS)-guided needle biopsy

According to the original drawing of D. F. Gleason,

Metastatic Ductal Adenocarcinoma of the Prostate Cytologic Features and Clinical Findings

Grading Prostate Cancer: Recent Changes and Refinements

Macro- and microacinar proliferations of the prostate

Select problems in cystic pancreatic lesions

Papillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I.

Update on Reporting Prostate Cancer Pathology

Recommendations for the Reporting of Prostate Carcinoma

USCAP 2012: Companion Meeting of the AAOOP. Update on lacrimal gland neoplasms: Molecular pathology of interest

Urinary Bladder: WHO Classification and AJCC Staging Update 2017

Disclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1

John N. Copeland, MD, 1 Mahul B. Amin, MD, 1 Peter A. Humphrey, MD, PhD, 2 Pheroze Tamboli, MD, 3 Jae Y. Ro, MD, PhD, 3 and Anthony A.

A re-audit of Prostate biopsies from January to December 2010 and 2013.

Procedures Needle Biopsy Transurethral Prostatic Resection Suprapubic or Retropubic Enucleation (Subtotal Prostatectomy) Radical Prostatectomy

Prostate Cancer Grading, Staging and Reporting: An Update Cristina Magi-Galluzzi, MD, PhD

Salivary Glands 3/7/2017

Updates in Urologic Pathology WHO Made Those Changes?! Peyman Tavassoli Pathology Department BC Cancer Agency

Basement membrane in lobule.

Histone H1.5 Expression in Prostatic Carcinoma: An Immunohistochemical Study

Chronic inflammation of long-standing duration has

Immunohistochemistry in prostate pathology: Recent Advances

Objectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells

In 2005, International Society of Urological Pathology

Internationally indexed journal

Papillary Lesions of the Breast: WHO Update

AGGRESSIVE VARIANTS OF PAPILLARY THYROID CARCINOMA DIAGNOSIS AND PROGNOSIS

1 NORMAL HISTOLOGY AND METAPLASIAS

ACCME/Disclosures. Case History 4/13/2016. USCAP GU Specialty Conference Case 3. Ann Arbor, MI

The Role of the Pathologist Active Surveillance for Prostate Cancer

ISPUB.COM. Interpretation Of Prostatic Biopsies: A Review. A Chitale, S Khubchandani INTRODUCTION NON-NEOPLASTIC LESIONS GRADING: GLEASON'S SCORE

Hyperplastic, Premalignant and Malignant Lesions of the Prostate Gland

Study of High Grade Prostatic Intraepithelial Neoplasia for a Period of Five Years B. Rajashekar Reddy 1, Rameswarapu Suman Babu 2 and P.

Percent Gleason pattern 4 in stratifying the prognosis of patients with intermediate-risk prostate cancer

Prostate cancer staging and datasets: The Nitty-Gritty. What determines our pathological reports? 06/07/2018. Dan Berney Maastricht 2018

6/3/2010. Outline of Talk. Lobular Breast Cancer: Definition of lobular differentiation. Common Problems in Diagnosing LCIS in Core Biopsies

Case: The patient is a 62 year old woman with a history of renal cell carcinoma that was removed years ago. A 2.4 cm liver mass was found on CT

Presentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98

International Society of Gynecological Pathologists Symposium 2007

Proliferative Breast Disease: implications of core biopsy diagnosis. Proliferative Breast Disease

Update on 2015 WHO Classification of Lung Adenocarcinoma 1/3/ Mayo Foundation for Medical Education and Research. All rights reserved.

University Journal of Pre and Para Clinical Sciences

Columnar Cell Lesions

Prostate Overview Quiz

Diagnostic Utility of Immunohistochemical Markers in Prostate Cancer

Prognostic value of the Gleason score in prostate cancer

Disease-specific death and metastasis do not occur in patients with Gleason score 6 at radical prostatectomy

Surgical Pathology Issues of Practical Importance

A 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy.

ASSESSMENT OF GLEASON SYSTEM USE ON DIFFERENT TYPES OF PROSTATIC TISSUE SAMPLES

Large blocks in prostate and bladder pathology

S1.04 PRINCIPAL CLINICIAN G1.01 COMMENTS S2.01 SPECIMEN LABELLED AS G2.01 *SPECIMEN DIMENSIONS (PROSTATE) S2.03 *SEMINAL VESICLES

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Prostate Case Scenario 1

STUDY OF PROSTATIC LESION FOR A PERIOD OF FIVE YEARS

Histological Type. Morphological and Molecular Typing of breast Cancer. Nottingham Tenovus Primary Breast Cancer Study. Survival (%) Ian Ellis

MEDICAL POLICY Genetic and Protein Biomarkers for Diagnosis and Risk Assessment of

Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance

Uropathology January Jon Oxley

Diagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018

Protocol for the Examination of Biopsy Specimens From Patients With Carcinoma of the Prostate Gland

04/10/2018. Intraductal Papillary Neoplasms Of Breast INTRADUCTAL PAPILLOMA

Some prostatic diseases

Transcription:

ORIGINAL ARTICLE High-grade Prostatic Intraepithelial Neoplasialike Ductal Adenocarcinoma of the Prostate: A Clinicopathologic Study of 28 Cases Fabio Tavora, MD* and Jonathan I. Epstein, MD*w z Abstract: Most of the prostatic ductal adenocarcinomas of the prostate are characterized by cribriform and/or papillary architecture lined by columnar pseudostratified malignant epithelium. We report 28 cases of ductal adenocarcinomas on needle biopsy and transurethral resection of prostate closely resembling high-grade prostatic intraepithelial neoplasia (HGPIN) composed of simple glands with flat, tufting, or micropapillary architecture. The mean age of the patients was 68 years (range, 50 to 91 y). Prostate specific antigen serum level at diagnosis ranged from 1.2 to 12.1 ng/ml. Treatment included radical prostatectomy (n = 9), hormone therapy (n = 7), radiotherapy (n = 5), and cryotherapy (n = 1). Three patients had recent biopsies without information on treatment and 3 patients were lost to follow-up after diagnosis. The number of cores involved by tumor in each case ranged from 1 to 18, with more than 1 core involved in 13 cases. Flat was the most common pattern (42%), followed by tufted (41%), and micropapillary (17%) (some with more than 1 pattern). Fourteen cases revealed segments of dilated gland on the edge of the biopsies, suggesting a large gland component. In radical prostatectomies, tumor was primarily composed of small (25%), medium (17%), or cystically dilated (58%) cancer glands, with all cases demonstrating a mixture of different gland sizes. Cytologically, tumors were characterized by tall columnar atypical cells, basally located nuclei, and amphophilic cytoplasm. The tumors lacked marked pleomorphism, necrosis, solid areas, cribriform formation, or true papillary fronds. Immunohistochemically, a-methyl acyl coenzyme-a racemase staining was seen in 93% of cases, with the majority showing strong and diffuse staining. No basal cells were present on p63 and/or high molecular weight cytokeratin staining. In the radical prostatectomy specimens, tumor volumes ranged from a small focus (less than 0.01 cm 3 ) to 1.2 cm 3. Concurrent conventional acinar Gleason score 6 adenocarcinomas were seen in 6 of the 9 radical prostatectomy cases, in all cases as separate nodules from the PIN-like ductal adenocarcinomas. Only one of the PIN-like ductal adenocarcinomas at radical prostatectomy had extraprostatic extension, which was focal. PIN-like ductal adenocarcinoma differs from HGPIN by the presence of cystically dilated glands, a From the Departments of *Pathology; wurology; and zoncology, The Johns Hopkins Medical Institutions, Baltimore, MD. Correspondence: Dr Jonathan I. Epstein, MD, Department of Pathology, 401 N. Broadway Street, Rm 2242, The Johns Hopkins Hospital, Baltimore, MD 21231 (e-mail: jepstein@jhmi.edu). Copyright r 2008 by Lippincott Williams & Wilkins greater predominance of flat architecture, and less frequently prominent nucleoli. Verification often requires the immunohistochemical documentation of the absence of basal cells in numerous atypical glands. Although usual ductal adenocarcinoma is considered comparable to Gleason score 8, PIN-like ductal adenocarcinoma was accompanied by Gleason score 6 acinar carcinoma and behaved similar to Gleason score 6 acinar cancer. Recognition of this entity is critical to differentiate it from both HGPIN and conventional ductal adenocarcinoma. Key Words: prostate cancer, high-grade intraepithelial neoplasia, ductal adenocarcinoma of the prostate (Am J Surg Pathol 2008;32:1060 1067) Prostatic ductal adenocarcinoma is a subtype of prostatic adenocarcinoma that was originally described as arising from the large primary periurethral ducts of the transition zone around the region of the verumontanum. Subsequently, it was reported to also arise in smaller secondary ducts within the peripheral zone, where it is typically detected on needle biopsy. Its prevalence is estimated to be around 1% of prostatic tumors. 2,3,5,8 Prostatic duct adenocarcinomas are morphologically characterized by pseudostratified columnar epithelium, typically arranged in cribriform or papillary formations. They are commonly associated with conventional high-grade acinar adenocarcinoma of the prostate. 2 High-grade prostatic intraepithelial neoplasia (HGPIN) has established immunohistochemical, genotypic, and morphologic similarities with prostatic adenocarcinoma and sometimes can pose diagnostic difficulties owing to its resemblance with invasive adenocarcinoma of the prostate. 3,5,7 Although most HGPIN are characterized by tufting epithelium, other morphologic appearances include flat, micropapillary, and cribriform. Although confusion between the micropapillary and especially cribriform patterns of HGPIN and ductal adenocarcinoma is well recognized, there has been only 1 study which has raised the issue of ductal adenocarcinomas closely resembling HGPIN with flat and tufted morphology. 10 We have termed this pattern as PIN-like prostatic duct adenocarcinoma. 1060 Am J Surg Pathol Volume 32, Number 7, July 2008

Am J Surg Pathol Volume 32, Number 7, July 2008 PIN-like Ductal Adenocarcinoma of the Prostate METHODS Twenty-eight cases of PIN-like ductal adenocarcinoma of the prostate were collected over 8 years from the consultation files of one of the authors from 1999 to 2007, with 24 cases over the last 3 years. The morphologic patterns, association with HGPIN and conventional acinar adenocarcinoma, and percentage of specimen involved were recorded. Immunohistochemical studies were performed either on the available paraffin blocks and/or submitted by contributors in 19 and 22 of the 28 cases, respectively. Immunohistochemistry was performed at our institution using antibodies against p63 and high molecular weight cytokeratin (HMWCK) (all predilutes, Ventana, Tucson, AZ), and a-methyl acyl coenzyme-a racemase (AMACR) (1:100, Zeta Corporation, Sierra Madre, CA). In addition, a predilute PIN-4 Cocktail (P504S+HMW CK+p63) from Biocare Medical (Concord, CA) was used in some cases. Positive results consisted of dark brown nuclear (p63) and cytoplasmic (34betaE12) staining of basal cells and red cytoplasmic granular staining (AMACR) of secretory epithelial cells. Appropriate positive and negative controls were included. Only staining that was moderate or strong was considered positive. Clinical follow-up was possible in all but 3 cases with an additional 3 recent cases having only short follow-up. RESULTS Clinical The mean age of the patients was 68 years (range, 50 to 91 y). All but 1 case was diagnosed on needle biopsies, with the 1 other case seen on transurethral resection. On 15 available cases, prostate specific antigen serum levels at diagnosis ranged from 1.2 to 12.1 ng/ml (mean 5.9). The clinicopathologic data are summarized in Table 1. Histology The numbers of cores involved by PIN-like ductal adenocarcinoma in each case ranged from 1 to 18, with more than 1 core involved in 13 (46%) of the cases. The average length of the positive cores involved by PIN-like ductal adenocarcinoma was 39% (range, 5% to 90%). In cases with a small percentage of the length of the core TABLE 1. Clinicopathologic Features No. Cores Involved/ Percent Overall Pathologic Study No. Age Total No. Cores Involvement Treatment Findings at RP Stage Follow-up (mo) 1 54 3/6 5 RP PLDCA and T2 NED (25) 2 66 1/4 40 LFU 3 70 1/5 20 BT NED (26) 4 54 3/5 70 RP PLDCA and T3a NED (8) 5 70 5/6 50 HT NED (32) 6 61 1/1 45 LFU 7 68 2/3 60 HT NED (17) 8 83 2/3 30 HT NED (2) 9 68 4/6 60 XRT NED (2) 10 77 2/3 40 HT NED (8) 11 74 1/3 25 CT NED (4) 12 69 8/10 40 LFU 13 63 1/2 10 RP PLDCA and T2 NED (5) 14 73 8/9 30 HT NED (8) 15 91 1/2 90 BT NED (9) 16 63 2/5 10 BT NED (6) 17 85 1/1 70 HT NED (5) 18 75 9/13 80 XRT NED (8) 19 77 5/8 50 HT NED (3) 20 50 4/10 30 RP PLDCA and T2 NED (4) 21 65 2/4 25 RP PLDCA and T2 NED (2) 22 71 18/24 20 RP PLDCA and T2 NED (3) 23 51 2/4 5 RP PLDCA T2 NED (3) 24 70 4/5 50 RP PLDCA T2 NED (5) 25 59 1/4 20 Recent 26 63 11/13 90 RP PLDCA T2 Recent 27 77 TURP 20 Recent 28 65 3/8 10 Recent BT indicates brachytherapy; CT, cryotherapy; HT, hormone therapy; LFU, lost to follow-up; NED, no evidence of disease; PLDCA, PIN-like ductal adenocarcinoma; RP, radical prostatectomy; TURP, transurethral resection; XRT, external beam radiotherapy. r 2008 Lippincott Williams & Wilkins 1061

Tavora and Epstein Am J Surg Pathol Volume 32, Number 7, July 2008 involved by tumor, a larger number of malignant glands were required to reach the diagnosis. Analogous to the architectural patterns seen in HGPIN, PIN-like ductal adenocarcinoma displayed flat (Figs. 1, 2), tufted (Fig. 3), and micropapillary (Fig. 4) patterns. The majority of cases (85%) showed a combination of 2 or more patterns, with flat and tufted the most common association. Overall, flat (42%) and tufted (41%) were the most frequent, followed by micropapillary (17%) (some with more than 1 pattern). PIN-like ductal adenocarcinoma glands were generally round with great variation in size. Dilated glands were too large to visualize their entire circumference on biopsy and only segments of the gland were seen on the edge of the core (Fig. 5). These dilated glands were seen on 14 needle biopsies. Smaller glands had a striking resemblance to HGPIN. The only difference was that in some areas, the small glands were more crowded and the cells FIGURE 2. A, High-power view of PIN-like ductal adenocarcinoma with typical cytology of ductal adenocarcinoma. Glands are lined by pseudostratified columnar epithelium with mildmoderate nuclear atypia and amphophilic cytoplasm. Although the glands are similar in size to those seen in HGPIN, the glands are more crowded than HGPIN. B, p63 immunohistochemical study showing absence of basal cells in PIN-like ductal adenocarcinoma glands. FIGURE 1. A, Low-power view of PIN-like ductal adenocarcinoma on needle biopsy showing crowded glands lined by columnar epithelium with a flat and tufting pattern. B, Triple antibody cocktail with intense AMACR positivity in PIN-like ductal adenocarcinoma and absence of basal cells (p63 and HMWCK). appear to overlap in a greater degree than HGPIN (Figs. 1A, 2A). In addition, the majority of the cases of PIN-like ductal adenocarcinoma showed less prominent nucleoli than HGPIN. In only 4 cases (14%), there were rare malignant glands with prominent nucleoli typical of HGPIN. The epithelium showed the morphology of prostatic ductal adenocarcinoma with tall columnar cells, basally located nuclei, and amphophilic cytoplasm (Figs. 2, 6). The tumors lacked marked pleomorphism, solid areas, dense cribriform formation, or necrosis. Mitoses were rare to absent. Two cases showed prominent Paneth-cell like neuroendocrine change (Fig. 3). Association with conventional acinar Gleason score 6 adenocarcinoma on the concurrent needle biopsy was observed in 5 cases (17%). HGPIN was found in 8(28%) cases with variability in the location of HGPIN, some 1062 r 2008 Lippincott Williams & Wilkins

Am J Surg Pathol Volume 32, Number 7, July 2008 PIN-like Ductal Adenocarcinoma of the Prostate FIGURE 3. A, PIN-like ductal adenocarcinoma with prominent paneth-cell like neuroendocrine differentiation. B, p63 immunohistochemical study showing absence of basal cells in PIN-like ductal adenocarcinoma glands. showing proximity and others away from PIN-like ductal adenocarcinoma. Immunohistochemistry In 27 (96%) cases, outside or in-house immunohistochemically stained slides were available for review. These cases consisted of 8 cases with HMWCK (34bE12,) only, 3 cases with p63 only, and 16 cases stained with the 3-antibody cocktail [HMWCK (34bE12),AMACR,and p63]. FIGURE 4. A, Tufted and micropapillary patterns of PIN-like ductal adenocarcinoma. B, HMWCK/p63 cocktail immunohistochemical study showing absence of basal cells. C, High power of PIN-like ductal adenocarcinoma gland with micropapillary formation. r 2008 Lippincott Williams & Wilkins 1063

Tavora and Epstein Am J Surg Pathol Volume 32, Number 7, July 2008 FIGURE 5. A, On both sides of the needle core, strips of malignant epithelium suggest the presence of cystically dilated glands. B, p63 immunohistochemical study showing absence of basal cells in the atypical dilated glands. Numerous identical negative glands were seen in this case. The only case without immunohistochemistry was diagnosed based on the presence of well-established micropapillae and presence of numerous glands lined by atypical columnar cells which resembled HGPIN, but were more crowded and involved 80% of 1 core. All cases with available immunohistochemical slides were uniformly negative for basal cell markers (p63 and/or HMWCK). AMACR was positive in 14 (93%) of the cases with available immunohistochemical slides with strong and diffuse staining in 12, focal in 2, and negative in 1 case. Findings at Radical Prostatectomy Nine (32%) patients underwent radical prostatectomy and had specimens available for review. The pathologic stages of the specimens were pt2 (organconfined) in 8 cases and pt3a (extraprostatic extension) in 1 case. Seminal vesicle involvement was not seen in any of the cases. All cases had conspicuous PIN-like ductal FIGURE 6. A, High power of PIN-like ductal adenocarcinoma resembling flat HGPIN. B, Antibody cocktail stained slide showing AMACR positivity in PIN-like ductal adenocarcinoma glands and absence of basal cells. This gland was surrounded by numerous other similar glands without basal cells. adenocarcinoma on the radical specimen with the exception of a sole case with only 1 small focus of PIN-like ductal adenocarcinoma. Association with conventional acinar adenocarcinoma was seen in 6 prostatectomies; in all these cases, the grade was Gleason score. In all available cases, PIN-like ductal adenocarcinoma and conventional acinar adenocarcinoma were anatomically distinct tumor foci. The majority of the PIN-like ductal adenocarcinoma showed architectural features similar to the biopsy with a mixture of small glands resembling HGPIN (Fig. 7) in addition to medium (Fig. 8) and large glands (Fig. 9). Overall, the majority of the PIN-like ductal adenocarcinoma glands in the radical prostatectomy specimens were of small, medium, and large glands in 25%, 17%, and 58% of the cases, respectively. No case had lymph node metastasis. Extraprostatic extension of tumor was documented in 1 radical 1064 r 2008 Lippincott Williams & Wilkins

Am J Surg Pathol Volume 32, Number 7, July 2008 PIN-like Ductal Adenocarcinoma of the Prostate FIGURE 7. Radical prostatectomy with PIN-like ductal adenocarcinoma show significant gland size variation from small to medium to large glands. prostatectomy specimen and in this case cystically dilated glands of PIN-like ductal adenocarcinoma were responsible for focal extraprostatic extension (Fig. 10). In the radical prostatectomy specimens, tumor volumes ranged from a small focus (less than 0.01 cm 3 ) to 1.5 cm 3, with the mean 0.51 cm 3. Follow-up The median follow-up was 5 months (mean, 10.8; range, 1 to 32 mo). Treatment included radical prostatectomy (n = 9), brachytherapy (n = 4), hormonal therapy (n = 7), cryotherapy (n = 1), and external beam radiation (n = 1). Three patients were lost to follow-up after diagnosis, and in 3 cases the recent diagnosis precluded therapeutic and prognostic information. In none of the patients has there been evidence of biochemical progression, local recurrence, or metastatic disease. FIGURE 9. Radical prostatectomy with cystically dilated glands. DISCUSSION PIN-like ductal adenocarcinoma is an unusual subset of prostatic adenocarcinoma that strikingly resembles HGPIN and has only been recently recognized. Hameed and Humphrey 10 reported 8 cases of what was called stratified epithelium in prostatic adenocarcinoma and was the first to highlight that this lesion mimics HGPIN. Their inclusion criterion was the presence of glands with stratified epithelium in the absence of cribriform formation. Although it was recognized that some of the cases resembled conventional prostatic ductal adenocarcinoma, they did not designate them as such. They chose to grade their cases as conventional acinar adenocarcinoma with assigned Gleason scores of in 6 cases and 3+4 = 7 in the other 2 cases. Reviewing 150 in-house consecutive cases, they estimated the incidence of PIN-like ductal adenocarcinoma was FIGURE 8. Radical prostatectomy with predominance of crowded medium-sized glands of PIN-like ductal adenocarcinoma. FIGURE 10. Radical prostatectomy with focal extraprostatic extension by cystically dilated glands of PIN-like ductal adenocarcinoma. r 2008 Lippincott Williams & Wilkins 1065

Tavora and Epstein Am J Surg Pathol Volume 32, Number 7, July 2008 1.3%. To the best of our knowledge, the only other report on this lesion is found in an abstract by Amin et al. 1 In our study, we have interpreted these lesions as variants of prostatic ductal adenocarcinoma on the basis of their similar cytologic characteristics. The hallmark of ductal adenocarcinoma is the presence of pseudostratified columnar epithelium in contrast to the simple cuboidal epithelium of acinar prostatic carcinoma. Although classic ductal adenocarcinoma consists of cribriform and papillary formation, it is recognized that other architectural patterns exist and that cytology and not the architecture defines this variant of prostate cancer. Most studies consider ductal morphology as a more aggressive morphologic phenotype with comparable behavior to Gleason score 8 acinar adenocarcinoma. 4,9,12 In a prior study from our institution on 58 prostate needle biopsy cases with ductal adenocarcinoma, 20 tumors were treated by radical prostatectomy. Extraprostatic spread of tumor was seen in 63%, positive margins in 20%, and seminal vesicle invasion in 10% of cases. 4 In contrast, in the current study of 10 patients with PIN-like ductal adenocarcinoma on needle biopsy who underwent radical prostatectomy, only 1 patient had tumor with focal extraprostatic extension. In addition, 1 of the patients who did not undergo radical prostatectomy had evidence of extraprostatic extension on the needle biopsy. Although the possibility exists that our prostatectomy specimens represent a selection bias with more aggressive tumors being treated by other modalities, the same selection bias was in affect with our prior study. Also even with the selection bias inherent in a surgical series, one would have expected more adverse findings in 10 radical prostatectomy specimens carried out for Gleason score 8 acinar adenocarcinoma. The current study, therefore, raises the issue of how to grade PIN-like ductal adenocarcinoma. The recommendation for grading usual prostatic ductal adenocarcinoma is to denote that they are comparable to Gleason score 4+4 = 8 acinar adenocarcinoma. 6 Our preliminary findings suggest that PIN-like ductal adenocarcinoma is less aggressive with behavior more akin to Gleason score 6 acinar adenocarcinoma. If one ignored the ductal cytology in these cases, the presence of single glands without necrosis or cribriform pattern would be analogous on the basis of architecture to Gleason score 6 acinar adenocarcinoma. In addition, of the associated conventional acinar adenocarcinomas seen in 6 prostatectomies within our series, all were Gleason pattern 3. This contrasts with typical ductal adenocarcinoma, where the accompanying acinar carcinoma, when present, is usually Gleason pattern 4. Until larger studies with long term follow-up are performed, we believe that it is reasonable not to assign a grade but to state in a comment that these tumors seem to be less aggressive than typical ductal adenocarcinoma and at this time may be best considered as Gleason score 6 for purposes of treatment and predicted prognosis. As its name indicates, PIN-like ductal adenocarcinoma on needle biopsy must be primarily distinguished from HGPIN. PIN-like ductal adenocarcinoma is distinct from HGPIN by the higher prevalence of flat epithelium, more crowded glands, and often large dilated glands. Although somewhat counterintuitive, PIN-like ductal adenocarcinomas may have less cytologic atypia than HGPIN. Whereas HGPIN by definition requires the presence of prominent nucleoli, PIN-like ductal adenocarcinoma often had tall-pseudostratified epithelium in the absence of visible nucleoli. If one were to misdiagnose these lesions as PIN, they would have to be considered low-grade PIN, yet the extensive nature of the process would be distinctly against the diagnosis of low-grade PIN. In addition to qualitative differences between HGPIN and PIN-like ductal adenocarcinoma, quantitative factors must also be taken into consideration. Extensive involvement of 1 or many needle cores is often necessary for the diagnosis. Focal HGPIN may be indistinguishable from PIN-like ductal adenocarcinoma both on the hematoxylin and eosin-stained slides and with immunohistochemistry, because scattered glands of HGPIN may not have a basal cell layer with HMWCK and/or p63 staining. Even in the cases where a small percentage of the biopsy was occupied by tumor, multiple glands were required to make a diagnosis of PIN-like ductal adenocarcinoma. Whereas an immunohistochemically documented absence of basal cells is often essential to establish the diagnosis of PIN-like ductal adenocarcinoma, AMACR overexpression seen in 93% of our cases is not helpful. The strong and diffuse staining seen in the majority of PIN-like ductal adenocarcinomas cannot be used to distinguish this lesion from its major mimicker, HGPIN, which is also often positive for AMACR. The rate of AMACR seen in our study was higher than reported by Hameed et al, where only 50% of the cases showed AMACR positivity, and is also high compared with conventional prostatic ductal adenocarcinoma. 10,11 Given that current recommendations for follow-up for HGPIN do not necessarily require immediate rebiopsy, it is all the more crucial that pathologists be aware of this distinct subtype of prostatic ductal adenocarcinoma and distinguish it from HGPIN. In addition, distinguishing this pattern of ductal adenocarcinoma from the more typical papillary and cribriform patterns is crucial, as PIN-like ductal adenocarcinoma seems to behave less aggressively than conventional ductal adenocarcinoma. REFERENCES 1. Amin MB, Cabrera RA, Lim SD. All that is micropapillary is not high-grade prostatic intraepithelial neoplasia (HG-PIN): Circumferential micropapillary perineural invasion (CMPNI) a potential pitfall in the recognition of invasive prostatic adenocarcinoma. Mod Pathol. 2003;15:139. 2. Bock BJ, Bostwick DG. Does prostatic ductal adenocarcinoma exist? Am J Surg Pathol. 1999;23:781 785. 3. Bostwick DG, Kindrachuk RW, Rouse RV. Prostatic adenocarcinoma with endometrioid features. Clinical, pathologic, and ultrastructural findings. Am J Surg Pathol. 1985;9:595 609. 1066 r 2008 Lippincott Williams & Wilkins

Am J Surg Pathol Volume 32, Number 7, July 2008 PIN-like Ductal Adenocarcinoma of the Prostate 4. Brinker DA, Potter SR, Epstein JI. Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression. Am J Surg Pathol. 1999;23:1471 1479. 5. Christensen WN, Steinberg G, Walsh PC, et al. Prostatic duct adenocarcinoma. Findings at radical prostatectomy. Cancer. 1991;67:2118 2124. 6. Epstein JI, Woodruff JM. Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases. Cancer. 1986;57:111 119. 7. Epstein JI, Netto GJ. Prostate Biopsy Interpretation. 4th ed. Lippincott Williams and Wilkins; 2002:54 57-218 227. 8. Epstein JI, Allsbrook WC Jr, Amin MB, et al. Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists. Adv Anat Pathol. 2006; 13:57 59. 9. Greene LF, Farrow GM, Ravits JM, et al. Prostatic adenocarcinoma of ductal origin. J Urol. 1979;121:303 305. 10. Hameed O, Humphrey PA. Stratified epithelium in prostatic adenocarcinoma: a mimic of high-grade prostatic intraepithelial neoplasia. Mod Pathol. 2006;19:899 906. 11. Herawi M, Epstein JI. Immunohistochemical antibody cocktail staining (p63/hmwck/amacr) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate. Am J Surg Pathol. 2007;31:889 894. 12. Ro JY, Ayala AG, Wishnow KI, et al. Prostatic duct adenocarcinoma with endometrioid features: immunohistochemical and electron microscopic study. Semin Diagn Pathol. 1988;5:301 311. r 2008 Lippincott Williams & Wilkins 1067